Genomic Vision Société Anonyme, headquartered in France, is a pioneering company in the field of genomics and molecular diagnostics. Founded in 2006, it has established itself as a leader in the development of innovative technologies for the analysis of DNA and genetic variations. The company primarily focuses on providing advanced solutions for cancer research and genetic disorders, utilising its proprietary DNA molecular combing technology. With a strong presence in Europe and expanding operations globally, Genomic Vision offers unique products and services that enable precise genomic analysis, setting it apart in the competitive landscape. Notable achievements include collaborations with leading research institutions and contributions to significant advancements in personalised medicine. As a key player in the genomics industry, Genomic Vision continues to drive innovation and enhance understanding of genetic complexities.
How does Genomic Vision Société Anonyme's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genomic Vision Société Anonyme's score of 28 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genomic Vision Société Anonyme, headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, Genomic Vision's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may need to establish clearer sustainability goals and reporting practices to align with industry standards and enhance its environmental accountability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genomic Vision Société Anonyme has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

